Pathobiochemistry of the extrapyramidal system: a “short note” review
@inproceedings{Riederer1989PathobiochemistryOT, title={Pathobiochemistry of the extrapyramidal system: a “short note” review}, author={P. Riederer and E. Sofi{\'c} and W. Rausch and G. Hebenstreit and J. Bruinvels}, year={1989} }
Evidence is presented to show that in Parkinson’s disease (PD) there exists a topographical degeneration in the nigrostriatal dopamine system. This finding may account for response variabilities and side effects occuring after antiparkinsonian therapy. Postsynaptic receptors do not show topical differences in both Bmax- and KD-values in treated PD. Postsynaptic receptors respond inadequately in about 30% of PD. Denervation supersensitivity may only occur in striatal subareas depleted of… CONTINUE READING
Topics from this paper
9 Citations
New horizons in molecular mechanisms underlying Parkinson's disease and in our understanding of the neuroprotective effects of selegiline.
- Chemistry, Medicine
- Journal of neural transmission. Supplementum
- 1996
- 22
Animal models of Parkinson's disease: An empirical comparison with the phenomenology of the disease in man
- Psychology, Medicine
- Journal of Neural Transmission
- 2005
- 347
Neurotransmitters, neuroreceptors and aging
- Biology, Medicine
- Mechanisms of Ageing and Development
- 1991
- 95
Dopaminergic dysfunction in alcoholism and schizophrenia--psychopathological and behavioral correlates.
- Psychology, Medicine
- European psychiatry : the journal of the Association of European Psychiatrists
- 2002
- 223
Sustained-release of levodopa: single dose study of a new formulation
- Chemistry, Medicine
- Journal of Neural Transmission
- 2005
- 3
References
SHOWING 1-10 OF 19 REFERENCES
The neurochemistry of Parkinson's disease: effect of L-dopa therapy.
- Chemistry, Medicine
- The Journal of pharmacology and experimental therapeutics
- 1975
- 391
A possible molecular mechanism for the antiparkinsonian action of bromocriptine in combination with levodopa
- Chemistry
- 1985
- 26
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
- Psychology, Physics
- Journal of the neurological sciences
- 1973
- 2,538
ENZYMES ASSOCIATED WITH THE METABOLISM OF CATECHOLAMINES, ACETYLCHOLINE AND GABA IN HUMAN CONTROLS AND PATIENTS WITH PARKINSON'S DISEASE AND HUNTINGTON'S CHOREA
- Psychology, Medicine
- Journal of neurochemistry
- 1976
- 477
Tyrosine Hydroxylase Activity in Caudate Nucleus from Parkinson's Disease: Effects of Iron and Phosphorylating Agents
- Biology, Medicine
- Journal of neurochemistry
- 1988
- 63
Dopamine D2 receptor density remains constant in treated Parkinson's disease
- Psychology, Medicine
- Annals of neurology
- 1986
- 93
CENTRAL DOPAMINERGIC AND SEROTONINERGIC SYSTEMS IN THE REGULATION OF ADRENAL TYROSINE HYDROXYLASE 1
- Biology, Medicine
- Journal of neurochemistry
- 1977
- 55
Transition Metals, Ferritin, Glutathione, and Ascorbic Acid in Parkinsonian Brains
- Chemistry, Medicine
- Journal of neurochemistry
- 1989
- 1,306
Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's, and Huntington's diseases.
- Chemistry, Medicine
- Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
- 1987
- 309